Ipamorelin in Canada: What GHSR-1a Selectivity Really Means

Ipamorelin is often described as “selective”, and the word is doing a lot of work. It does not mean the peptide picks one receptor subtype out of many. It refers to how narrow its endocrine profile looked in the original pharmacology compared with earlier compounds that act at the same receptor. For labs sourcing ipamorelin in Canada, understanding what that selectivity claim does and does not cover is the first step in designing sensible experiments. This article covers the receptor, the structure, the comparison with older secretagogues, and what to check on a volume order.

The target: GHSR-1a

Ipamorelin is an agonist at the growth hormone secretagogue receptor type 1a (GHSR-1a), the receptor whose natural ligand is ghrelin. GHSR-1a is a class A G protein-coupled receptor that signals mainly through Gq, raising intracellular calcium. It is expressed in pituitary somatotrophs and in several brain regions, and it has an unusually high level of constitutive activity, meaning it signals to some degree even with no ligand bound.

A splice variant, GHSR-1b, is truncated and does not bind ghrelin or synthetic secretagogues in the same way, so when papers talk about the ipamorelin receptor they mean GHSR-1a. This is a different receptor from the GHRH receptor targeted by sermorelin, tesamorelin and Mod GRF 1-29, which is why the two classes are frequently studied together.

The natural ligand explains why small synthetic agonists became attractive research tools. Ghrelin is a 28-residue peptide whose third residue, a serine, carries an octanoyl ester. That fatty-acid group is required for binding GHSR-1a, and it is easily lost by hydrolysis in biological samples, leaving des-acyl ghrelin that does not activate the receptor in the same way. Short secretagogues such as ipamorelin need no acyl modification at all, which makes them simpler to synthesise, store and quantify than the endogenous hormone.

Ipamorelin’s structure

Ipamorelin is a pentapeptide containing three non-standard building blocks:

Aib-His-D-2-Nal-D-Phe-Lys-NH2

• Aib (α-aminoisobutyric acid) has two methyl groups on its alpha carbon, which restricts backbone flexibility and resists enzymatic cleavage.
• D-2-Nal (D-3-(2-naphthyl)alanine) is a bulky aromatic residue in the D-configuration.
• D-Phe is the D-isomer of phenylalanine.
• The C-terminal lysine is amidated.

Reference data: molecular formula C38H49N9O5, molecular weight about 711.9 g/mol, CAS 170851-70-4. The D-residues and Aib make the molecule far more resistant to peptidases than a natural pentapeptide would be.

What ipamorelin selectivity actually means

Ipamorelin came out of a medicinal chemistry programme in the 1990s that built on earlier growth hormone-releasing peptides (GHRPs). Those older compounds, such as GHRP-6 and GHRP-2, act at the same GHSR-1a receptor. In the original pharmacological characterisation, using pituitary cells in vitro and animal models, the earlier GHRPs increased growth hormone release but were also associated with rises in ACTH and cortisol, and in some reports prolactin.

Ipamorelin was reported to release growth hormone with potency comparable to GHRP-6 while producing little or no change in ACTH or cortisol, even at exposures well above those needed for growth hormone release. That is the selectivity in question: selectivity of downstream hormonal response, measured in those preclinical models, rather than selectivity between receptor subtypes.

Two cautions follow for anyone building on that literature:

1. The selectivity profile was established in specific preclinical systems. It should be confirmed, not assumed, in any new model.
2. Because all these compounds share one receptor, the difference is thought to lie in how each ligand engages GHSR-1a and downstream pathways, which is an area where mechanistic detail remains limited.

Ipamorelin and the older GHRPs compared

The shared C-terminal D-Phe-Lys-NH2 motif is visible across all three. Ipamorelin is the shortest and the only one with no tryptophan, which also removes a residue that is prone to oxidation in the older peptides.

Sourcing ipamorelin in Canada: identity and purity checks

The non-standard residues make ipamorelin simple to identify by mass but slightly unusual to analyse. A few points help a QC lab reading certificates or running its own checks:

• Mass first. A main species near 712 Da confirms identity; the older GHRPs sit well above it.
• Stereochemistry is invisible to MS. An L-isomer impurity at the D-Nal or D-Phe position has the same mass as the target. Only a chromatographic method able to resolve diastereomers will show it, so look for a chromatogram rather than a mass alone.
• Amino acid analysis is incomplete. Standard AAA does not report Aib or 2-Nal the way it does natural residues, so content methods need to account for that.
• Blends. Ipamorelin is often supplied with Mod GRF 1-29 in one vial. The two separate cleanly by reversed-phase HPLC, and each component deserves its own purity figure.

Handling a multi-vial order

Ipamorelin is comparatively robust as a freeze-dried solid, but good receiving habits still apply. Count vials against the packing slip on arrival, match cap and crimp colour to the certificate where one is published, record the pairing, and move sealed vials to cold, dark storage the same day. Allow vials to warm to room temperature before opening, and prepare analytical solutions only as needed.

For long projects, request one lot for the full quantity and specify sequence, mass and minimum HPLC purity in writing, so any reorder can be checked against the same standard. Bulk Peptides lists ipamorelin on its own and in a CJC-1295 and ipamorelin blend. Our products are third-party tested for purity by HPLC, certificates are published for some products, and vials are matched to their certificate by cap and crimp colour. Mix-and-match pricing means every vial in the cart counts toward the volume break, and orders ship from within Canada.

Ipamorelin is sold by Bulk Peptides for in-vitro laboratory research only. It is not for human or animal use, and this article does not describe or recommend any such use.